Early conference research from University of Colorado Anschutz suggests blood plasma markers may help predict depression response to psilocybin or ketamine, but the finding remains unvalidated and unavailable clinically.
Blood Markers May Signal Who Benefits From Psilocybin or Ketamine for Depression in Early Conference Research
by | Nov 17, 2026 | Uncategorized | 0 comments

Recent Comments